This Title All WIREs
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 7.689

Recent developments in the use of organic–inorganic nanohybrids for drug delivery

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Abstract Organic–inorganic nanohybrid (OINH) structures providing a versatile platform for drug delivery with improved characteristics are an area which has gained recent attention. Much effort has been taken to develop these structures to provide a viable treatment options for much alarming diseases such as cancer, bone destruction, neurological disorders, and so on. This review focuses on current work carried out in producing different types of hybrid drug carriers identifying their properties, fabrication techniques, and areas where they have been applied. A brief introduction on understating the requirement for blending organic–inorganic components into a nanohybrid drug carrier is followed with an elaboration given about the different types of OINHs developed currently highlighting their properties and applications. Then, different fabrication techniques are discussed given attention to surface functionalization, one‐pot synthesis, wrapping, and electrospinning methods. Finally, it is concluded by briefing the challenges that are remaining to be addressed to obtain multipurpose nanohybrid drug carriers with wider applicability. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies
Microbead structure of sodium diclofenac (SD)–montmorillonite (MMT)–sodium alginate (SA) and mechanism of drug release. (Reprinted with permission from Raut, Gahane, Joshi, Kalthur, and Mutalik (). Copyright 2019 Elsevier Ltd)
[ Normal View | Magnified View ]
Schematic representation of preparation of b‐CD‐(PLA‐PDMAEMA‐PEtOxMA)21/Au/doxorubicin (DOX) and its' application as a drug carrier and a computer tomography (CT) imaging agent under in vivo and in vitro conditions (Reprinted with permission from W. Lin et al., (). Copyright 2017 Acta Materialia Inc. Published by Elsevier Ltd)
[ Normal View | Magnified View ]
Schematic illustration of theranostics cerasome platform, composed of Gly@Cy7 and Cerasome forming lipid then loaded with doxorubicin (DOX), designed for near‐infrared (NIR) controlled photothermal therapy (PTT) and chemotherapy simultaneously with NIR scanning ability for cancer treatment. (Reprinted with permission from Zhang et al. (). Copyright 2019 Royal Society of Chemistry)
[ Normal View | Magnified View ]
Doxorubicin (DOX)‐loaded MWCNT/TiO2@‐Au nanodrug carrier exerting a pH‐responsive drug release when delivered to the tumor site (Reprinted with permission from Karthika et al. (). Copyright 2018 Elsevier Ltd)
[ Normal View | Magnified View ]
Codelivery of curcumin and doxorubicin (DOX) via a HAPONH carrier to MCF‐7 and HEpG2 cells, exhibiting a magnetic targeted delivery and pH‐sensitive drug release leading to a higher cell death. (Reprinted with permission from Manatunga, de Silva, Nalin de Silva, et al., (). Copyright 2018 Elsevier Ltd)
[ Normal View | Magnified View ]
Fabrication of ZnO quantum dot (QD) bound porous silica nanospheres for pH‐/redox‐responsive doxorubicin (DOX) release, a study carried out by Zhang et al. (2018) (Reprinted with permission from X. Zhang, Zhao, Cao, & Sun, . Copyright 2018 Elsevier Inc.)
[ Normal View | Magnified View ]
Illustration of the SPIONs heparin‐poloxamer (SPION@HP) core shell structure formation for doxorubicin (DOX) drug loading in the study carried out by Thi and colleagues (Reprinted with permission from Thi et al. (). Copyright Creative Commons Attribution (CC BY) license)
[ Normal View | Magnified View ]
pH‐responsive charge reversal of doxorubicin (DOX)‐loaded MSN‐hyd‐morpholin‐4‐yl‐acetyl‐poly(ethylene glycol)‐b‐poly(lactic acid) (MOP) enhancing the cellular uptake and drug release in drug delivery to cancer cells (Reprinted with permission from Yuan et al. (). Copyright 2019 Elsevier Inc.)
[ Normal View | Magnified View ]
A schematic diagram showing (a) the general structure of layered double hydroxide (LDH), (b) the chemical structures of ibu and ket, and (c) the strategy adopted in the poly(caprolactone) (PCL)/LDH‐drug clay‐polymer nanohybrids (CPNH) fibers. (Reprinted with permission from Gao et al. () Copyright 2017 Royal Society of Chemistry)
[ Normal View | Magnified View ]

Browse by Topic

Therapeutic Approaches and Drug Discovery > Emerging Technologies

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts